scispace - formally typeset
A

Anuj Sharma

Researcher at Chandragupt Institute of Management

Publications -  145
Citations -  3043

Anuj Sharma is an academic researcher from Chandragupt Institute of Management. The author has contributed to research in topics: Chemistry & Venezuelan equine encephalitis virus. The author has an hindex of 23, co-authored 114 publications receiving 2186 citations. Previous affiliations of Anuj Sharma include AIIMS, New Delhi & Dr. B. R. Ambedkar National Institute of Technology Jalandhar.

Papers
More filters
Journal ArticleDOI

Advancing Sustainable Development Goals through Interdisciplinarity in Sustainable Tourism Research

TL;DR: In this article, the authors explored the interdisciplinarity of research published in the Journal of Sustainable Tourism using references cited by the journal's articles and used structural topic modeling to analyze research trends.
Proceedings ArticleDOI

A boosted SVM based sentiment analysis approach for online opinionated text

TL;DR: The proposed model exploits classification performance of two techniques (Boosting and SVM) applied for the task of sentiment based classification of online reviews and shows that SVM ensemble with bagging or boosting significantly outperforms a single SVM in terms of accuracy of sentimentbased classification.
Journal ArticleDOI

Lyme disease: A case report with typical and atypical lesions

TL;DR: A 10-year-old young boy from a non-endemic zone of Himachal Pradesh, who presented with typical as well as atypical ECM lesions, was diagnosed with Lyme disease and treated successfully with doxycycline.
Journal ArticleDOI

Inactivation of Chikungunya virus by 1,5 iodonapthyl azide

TL;DR: This study demonstrates the complete inactivation of CHIKV181/25 by 1,5 iodonapthyl azide (INA) and can be explored for developing an inactivated-CHIKV vaccine.
Journal ArticleDOI

Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts.

TL;DR: Data suggests that Akt-phosphorylation can be an amenable target of therapy against CHIKV infection, and presents a case for further development of MF as an anti-CHIKV drug.